on AlzChem Group AG (isin : DE000A0AHT46)
Alzchem Advances Nitroguanidine Production in the U.S.
On November 16, 2026, Alzchem Group AG announced significant strides in its planned nitroguanidine production facility in the U.S. This project, aimed at solidifying its role in the North American defense market, has progressed with the Supervisory Board's approval to procure essential long-lead-time components. This advancement sets the stage for the next phase of project implementation.
The financial backing comes from the U.S. Department of Defense, which has committed to covering the production facility's costs. The parties are finalizing contractual details as the project moves along. The facility, located in Bushy Park, South Carolina, is expected to be operational by 2029. Alzchem will source precursors from Germany, strengthening both U.S. supply chains and German value creation.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AlzChem Group AG news